Acadian Asset Management’s PDL BioPharma, Inc. PDLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q3
Sell
-189,866
Closed -$596K 2109
2019
Q2
$596K Sell
189,866
-847,980
-82% -$2.66M ﹤0.01% 961
2019
Q1
$3.86M Sell
1,037,846
-1,244,873
-55% -$4.63M 0.02% 506
2018
Q4
$6.62M Sell
2,282,719
-514,485
-18% -$1.49M 0.03% 335
2018
Q3
$7.36M Sell
2,797,204
-1,202,454
-30% -$3.16M 0.03% 325
2018
Q2
$9.36M Sell
3,999,658
-749,801
-16% -$1.75M 0.04% 305
2018
Q1
$14M Sell
4,749,459
-531,829
-10% -$1.56M 0.06% 242
2017
Q4
$14.5M Hold
5,281,288
0.06% 236
2017
Q3
$17.9M Buy
5,281,288
+458,356
+10% +$1.55M 0.08% 209
2017
Q2
$11.9M Sell
4,822,932
-2,756
-0.1% -$6.81K 0.05% 260
2017
Q1
$11M Sell
4,825,688
-677,597
-12% -$1.54M 0.05% 271
2016
Q4
$11.7M Sell
5,503,285
-592,640
-10% -$1.26M 0.06% 263
2016
Q3
$20.4M Sell
6,095,925
-139,899
-2% -$469K 0.1% 183
2016
Q2
$19.6M Buy
6,235,824
+156,534
+3% +$491K 0.1% 179
2016
Q1
$20.2M Sell
6,079,290
-76,160
-1% -$254K 0.1% 197
2015
Q4
$21.8M Buy
6,155,450
+2,597,425
+73% +$9.2M 0.11% 193
2015
Q3
$17.9M Sell
3,558,025
-1,129,948
-24% -$5.68M 0.1% 206
2015
Q2
$30.1M Sell
4,687,973
-1,767,611
-27% -$11.4M 0.15% 164
2015
Q1
$45.4M Buy
6,455,584
+483,911
+8% +$3.4M 0.21% 135
2014
Q4
$46M Sell
5,971,673
-621,771
-9% -$4.79M 0.21% 132
2014
Q3
$49.3M Buy
6,593,444
+106,432
+2% +$795K 0.24% 120
2014
Q2
$62.8M Buy
6,487,012
+885,500
+16% +$8.57M 0.31% 86
2014
Q1
$46.5M Sell
5,601,512
-114,060
-2% -$948K 0.24% 101
2013
Q4
$48.2M Buy
5,715,572
+91,195
+2% +$770K 0.27% 92
2013
Q3
$44.8M Sell
5,624,377
-37,806
-0.7% -$301K 0.29% 94
2013
Q2
$43.7M Buy
+5,662,183
New +$43.7M 0.3% 91